HRA Update: New inclusion and diversity guidance
Date: 24 October 2024
The HRA have launched an informal consultation on draft inclusion and diversity guidance they are producing with the Medicines and Healthcare products Regulatory Agency (MHRA).
The guidance will help ensure research is designed to include people who could be impacted by the findings, and that people underserved by research are not overlooked. The HRA hope that this will help increase the diversity of people taking part in clinical trials and clinical investigations.
This is part of the HRAs wider work with the MHRA to update the UK’s clinical trials regulations.